A simple blood test using a single drop of blood is significantly more accurate than current screening methods. The new test will allow men to bypass invasive procedures to look for aggressive prostate cancer
The new Extracellular Vesicle Fingerprint Predictive Score (EV-FPS) test uses a computer to combine information from millions of cancer cell nanoparticles in the blood to… Read More »
Researchers from Massachusetts General Harvard, Dana Farber Cancer Institute and Brigham and Women’s Hospital recently revealed that long-term use of aspirin is associated with lower risk of dying from various types of cancers, including lung and prostate cancer. Both cancers are the leading killers of men. The findings were presented at the April 2017 meeting of the American Association for Cancer Research.
Apparently aspirin not only reduces the risk of developing… Read More »
Tagged with: American Cancer Society, annual physical, Bayer, diet and prostate cancer, enlarged prostate, Harvard Medical School, men who speak up, National Mens Health Awareness Initiative, PSA, US Preventative Services Taskforce, ZERO
When it comes to speaking about issues occurring below the belt-line, 90% of men will ignore the subject or retreat into silence. Unlike women, who openly share life-saving information on their health with their physicians and friends, men tend to “macho up” and retreat into quiet isolation. Additional conversation is generally not an option.
The end result of this self-imposed wall of silence by men has been the re-allocation of… Read More »
Tagged with: America Cancer Society, annual physical, diet and prostate cancer, enlarged prostate, men who speak up, prostate cancer diagnosis, PSA, PSA Testing, real men speak up, regular check ups, US Preventative Services Taskforce, ZERO
Diagnoses of early prostate cancer continue to decline in the United States, following the 2011 U.S. Preventive Services Task Force (USPSTF) recommendation against routine screening for the disease.
For those of you not familiar with this screening, the analysis involves a simple blood test that identifies levels of PSA (prostate specific antigen), a protein produced by the prostate gland. While the test can determine when cancer exists, it can… Read More »
Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body, but the PSA test remains highly controversial as it frequently leads to over diagnosis and over treatment of men who may not be at risk. Smarter screening strategies that can improve the accuracy of diagnosing lethal prostate cancer are urgently needed. Through a prospective… Read More »
Tagged with: African American Men, annual physical, Bayer, Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Mark Preston, MD, men who speak up, MPH, Physicians' Health Study, real men get tested, ZERO
Jeff Jones was aware of the risks associated with high Prostate-Specific Antigen (PSA) levels.
In January 2015 after an annual checkup, doctors told him his PSA levels were high and encouraged further monitoring. He underwent blood work and a biopsy that revealed nothing more than what he already knew.
So when doctors suggested he receive one more biopsy after failed attempts to lower his PSA, Jones was in no rush… Read More »